Insmed - 35 Year Stock Price History | INSM

Historical daily share price chart and data for Insmed since 1991 adjusted for splits and dividends. The latest closing stock price for Insmed as of January 22, 2026 is 160.39.

The all-time high Insmed stock closing price was 760.00 on December 30, 1991.
The Insmed 52-week high stock price is 212.75, which is 32.6% above the current share price.
The Insmed 52-week low stock price is 60.40, which is 62.3% below the current share price.
The average Insmed stock price for the last 52 weeks is 120.82.

Insmed Historical Annual Stock Price Data
Year	Average Stock Price	Year Open	Year High	Year Low	Year Close	Annual % Change
2026	167.5314	177.1200	177.1200	156.3200	160.3900	-7.84%
2025	115.3973	69.9500	211.4100	64.8100	174.0400	152.09%
2024	53.5032	29.9400	79.0100	22.0000	69.0400	122.78%
2023	21.8217	19.1800	31.7400	16.2600	30.9900	55.11%
2022	21.8800	28.1300	28.2100	16.9800	19.9800	-26.65%
2021	30.5951	33.4200	44.3000	22.4600	27.2400	-18.17%
2020	28.2231	23.6600	40.5400	13.6300	33.2900	39.41%
2019	23.3077	13.9700	32.1900	13.9100	23.8800	82.01%
2018	22.6387	32.4600	32.9900	11.6000	13.1200	-57.92%
2017	20.2914	13.0800	31.7800	11.6100	31.1800	135.68%
2016	12.7351	17.2400	17.2400	9.0500	13.2300	-27.11%
2015	20.7534	15.9600	27.5400	14.1600	18.1500	17.32%
2014	15.7364	17.1400	21.5400	11.6500	15.4700	-9.00%
2013	11.2478	6.9600	17.3300	5.7200	17.0000	154.11%
2012	4.3827	3.1500	8.0000	2.7000	6.6900	119.34%
2011	6.4065	6.4000	13.1500	2.6400	3.0500	-51.65%
2010	8.1390	7.7000	12.5000	5.7000	6.3080	-18.08%
2009	9.7689	4.9000	24.7000	4.1500	7.7000	64.71%
2008	6.0865	8.3000	9.1000	3.4990	4.6750	-43.33%
2007	8.8034	9.0000	15.6000	5.7700	8.2500	-6.25%
2006	16.1199	21.3000	31.2000	8.5000	8.8000	-55.33%
2005	12.6981	23.0000	23.0000	8.2000	19.7000	-10.41%
2004	23.1546	30.3000	40.9000	10.1000	21.9900	-25.96%
2003	20.0217	4.8000	34.2000	4.1000	29.7000	561.47%
2002	17.7450	39.4000	39.4000	3.5000	4.4900	-88.25%
2001	45.0065	37.5000	89.9000	24.7000	38.2000	10.12%
2000	166.4676	110.0000	455.0000	26.8750	34.6880	-69.84%
1999	57.0461	67.5000	115.0000	33.7520	115.0000	70.37%
1998	77.4331	70.0000	155.0000	20.0000	67.5000	-6.90%
1997	100.8424	82.5000	155.0000	66.2480	72.5000	-9.38%
1996	101.0310	105.0000	157.5000	72.5000	80.0000	-21.95%
1995	83.9087	102.5000	120.0000	50.0000	102.5000	-2.38%
1994	253.8046	445.0000	460.0000	80.0000	105.0000	-76.14%
1993	319.4862	390.0000	445.0000	230.0000	440.0000	10.00%
1992	358.3858	710.0000	720.0000	210.0000	400.0000	-45.21%

Sector	Industry	Market Cap	Revenue
Medical	Medical - Biomedical and Genetics	$33.339B	$0.364B
Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas aeruginosa lung infections. Insmed is also focused on the development of INS1009, the company's inhaled treprostinil prodrug for the treatment of pulmonary arterial hypertension (PAH), a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs.

Stock Name	Country	Market Cap	PE Ratio
AstraZeneca (AZN)	United Kingdom	$280.838B	19.81
Amgen (AMGN)	United States	$185.022B	15.71
Gilead Sciences (GILD)	United States	$160.184B	15.76
Vertex Pharmaceuticals (VRTX)	United States	$117.000B	30.12
Bristol Myers Squibb (BMY)	United States	$110.949B	8.31
GSK (GSK)	United Kingdom	$97.986B	10.85
Regeneron Pharmaceuticals (REGN)	United States	$78.754B	20.43
CSL (CSLLY)	Australia	$58.422B	0.00
Argenex SE (ARGX)	Netherlands	$50.520B	62.41
Alnylam Pharmaceuticals (ALNY)	United States	$48.282B	1588.96
BioNTech SE (BNTX)	Germany	$26.571B	0.00
Biogen (BIIB)	United States	$25.324B	10.31
Illumina (ILMN)	United States	$23.299B	34.97
Royalty Pharma (RPRX)	United States	$22.928B	8.79
Revolution Medicines (RVMD)	United States	$22.721B	0.00
Genmab (GNMSF)	Denmark	$21.623B	15.86
Genmab (GMAB)	Denmark	$21.167B	15.92
Incyte (INCY)	United States	$20.549B	19.67
Exact Sciences (EXAS)	United States	$19.554B	539.37
Moderna (MRNA)	United States	$19.462B	0.00
Roivant Sciences (ROIV)	United Kingdom	$15.982B	0.00
Guardant Health (GH)	United States	$14.589B	0.00
Ascendis Pharma (ASND)	Denmark	$13.428B	0.00
Swedish Orphan Biovitrum (BIOVF)	Sweden	$13.172B	24.50
Exelixis (EXEL)	United States	$12.014B	19.23
QIAGEN (QGEN)	Netherlands	$11.754B	22.31
Bio-Techne Corp (TECH)	United States	$11.121B	41.50
Avidity Biosciences (RNA)	United States	$10.947B	0.00
BioMarin Pharmaceutical (BMRN)	United States	$10.906B	19.78
Regencell Bioscience Holdings (RGC)	Hong Kong, SAR China	$10.834B	0.00
Jazz Pharmaceuticals (JAZZ)	Ireland	$10.279B	40.08
Repligen (RGEN)	United States	$9.568B	102.39
Axsome Therapeutics (AXSM)	United States	$9.533B	0.00
Abivax SA (ABVX)	France	$9.414B	0.00
Arrowhead Pharmaceuticals (ARWR)	United States	$9.185B	0.00
Bio-Rad Laboratories (BIO.B)	United States	$8.436B	30.33
Halozyme Therapeutics (HALO)	United States	$8.433B	13.48
Krystal Biotech (KRYS)	United States	$8.293B	42.88
Nuvalent (NUVL)	United States	$7.928B	0.00
Praxis Precision Medicines (PRAX)	United States	$7.876B	0.00
Cytokinetics (CYTK)	United States	$7.708B	0.00
Rhythm Pharmaceuticals (RYTM)	United States	$7.071B	0.00
Cidara Therapeutics (CDTX)	United States	$6.960B	0.00
Merus (MRUS)	Netherlands	$6.826B	0.00
ImmunityBio (IBRX)	United States	$6.816B	0.00
Vaxcyte (PCVX)	United States	$6.574B	0.00
PTC Therapeutics (PTCT)	United States	$6.067B	8.24
Belite Bio (BLTE)	United States	$5.972B	0.00
Structure Therapeutics (GPCR)	United States	$5.691B	0.00
Cogent Biosciences (COGT)	United States	$5.681B	0.00
Apogee Therapeutics (APGE)	United States	$5.596B	0.00
Alkermes (ALKS)	Ireland	$5.589B	16.43
Protagonist Therapeutics (PTGX)	United States	$5.244B	135.31
CRISPR Therapeutics AG (CRSP)	Switzerland	$5.216B	0.00
Kymera Therapeutics (KYMR)	United States	$5.090B	0.00
TG Therapeutics (TGTX)	United States	$5.012B	11.36
Celcuity (CELC)	United States	$4.958B	0.00
Anbio Biotechnology (NNNN)	Germany	$4.833B	0.00
Mirum Pharmaceuticals (MIRM)	United States	$4.793B	0.00
Scholar Rock Holding (SRRK)	United States	$4.697B	0.00
CG Oncology (CGON)	United States	$4.608B	0.00
Immunovant (IMVT)	United States	$4.561B	0.00
ACADIA Pharmaceuticals (ACAD)	United States	$4.527B	38.23
Zealand Pharma (ZLDPF)	Denmark	$4.511B	4.57
Akero Therapeutics (AKRO)	United States	$4.499B	0.00
Amicus Therapeutics (FOLD)	United States	$4.427B	358.75
ADMA Biologics Inc (ADMA)	United States	$4.132B	29.42
Arcellx (ACLX)	United States	$3.982B	0.00
GRAIL (GRAL)	United States	$3.940B	0.00
Ligand Pharmaceuticals (LGND)	United States	$3.927B	96.38
Legend Biotech (LEGN)	United States	$3.834B	0.00
Viking Therapeutics (VKTX)	United States	$3.773B	0.00
Liquidia (LQDA)	United States	$3.479B	0.00
Terns Pharmaceuticals (TERN)	United States	$3.302B	0.00
Arcutis Biotherapeutics (ARQT)	United States	$3.271B	0.00
Kiniksa Pharmaceuticals (KNSA)	United Kingdom	$3.171B	92.96
Xenon Pharmaceuticals (XENE)	Canada	$3.168B	0.00
Beam Therapeutics (BEAM)	United States	$3.158B	0.00
IDEAYA Biosciences (IDYA)	United States	$3.157B	0.00
Edgewise Therapeutics (EWTX)	United States	$3.096B	0.00
Viridian Therapeutics (VRDN)	United States	$3.082B	0.00
Tarsus Pharmaceuticals (TARS)	United States	$3.021B	0.00
Vera Therapeutics (VERA)	United States	$2.926B	0.00
Erasca (ERAS)	United States	$2.851B	0.00
Disc Medicine (IRON)	United States	$2.827B	0.00
Alumis (ALMS)	United States	$2.785B	0.00
HUTCHMED (China) (HCM)	Hong Kong, SAR China	$2.765B	0.00
Denali Therapeutics (DNLI)	United States	$2.728B	0.00
Adaptive Biotechnologies (ADPT)	United States	$2.682B	0.00
Twist Bioscience (TWST)	United States	$2.675B	0.00
Apellis Pharmaceuticals (APLS)	United States	$2.651B	67.58
Spyre Therapeutics (SYRE)	United States	$2.637B	0.00
Travere Therapeutics (TVTX)	United States	$2.528B	0.00
Arcus Biosciences (RCUS)	United States	$2.478B	0.00
Mineralys Therapeutics (MLYS)	United States	$2.478B	0.00
Telix Pharmaceuticals (TLX)	Australia	$2.476B	0.00
Ascentage Pharma Group - (AAPG)	China	$2.463B	0.00
Bavarian Nordic (BVNRY)	Denmark	$2.436B	6.61
Recursion Pharmaceuticals (RXRX)	United States	$2.396B	0.00
WAVE Life Sciences (WVE)	Singapore	$2.331B	0.00
Immunome (IMNM)	United States	$2.281B	0.00
Sarepta Therapeutics (SRPT)	United States	$2.239B	0.00
Mesoblast (MESO)	Australia	$2.227B	0.00
Ultragenyx Pharmaceutical (RARE)	United States	$2.195B	0.00
Harmony Biosciences Holdings (HRMY)	United States	$2.113B	11.54
Zai Lab (ZLAB)	China	$2.109B	0.00
Nuvation Bio (NUVB)	United States	$2.108B	0.00
Maze Therapeutics (MAZE)	United States	$2.103B	0.00
Dianthus Therapeutics (DNTH)	United States	$2.059B	0.00
ANI Pharmaceuticals (ANIP)	United States	$1.922B	14.90
Vericel (VCEL)	United States	$1.908B	157.17
MBX Biosciences (MBX)	United States	$1.845B	0.00
Dynavax Technologies (DVAX)	United States	$1.841B	54.07
Sionna Therapeutics (SION)	United States	$1.820B	0.00
Olema Pharmaceuticals (OLMA)	United States	$1.805B	0.00
Zymeworks (ZYME)	United States	$1.792B	0.00
Syndax Pharmaceuticals (SNDX)	United States	$1.783B	0.00
Immunocore Holdings (IMCR)	United Kingdom	$1.783B	0.00
MannKind (MNKD)	United States	$1.753B	57.10
Celldex Therapeutics (CLDX)	United States	$1.739B	0.00
Upstream Bio (UPB)	United States	$1.707B	0.00
Definium Therapeutics (DFTX)	United States	$1.689B	0.00
Stoke Therapeutics (STOK)	United States	$1.685B	44.03
Tango Therapeutics (TNGX)	United States	$1.685B	0.00
Corvus Pharmaceuticals (CRVS)	United States	$1.654B	0.00
NeoGenomics (NEO)	United States	$1.642B	0.00
Intellia Therapeutics (NTLA)	United States	$1.625B	0.00
Novavax (NVAX)	United States	$1.609B	4.09
Rapt Therapeutics (RAPT)	United States	$1.596B	0.00
Agios Pharmaceuticals (AGIO)	United States	$1.584B	0.00
Precigen (PGEN)	United States	$1.578B	0.00
Monte Rosa Therapeutics (GLUE)	United States	$1.578B	75.72
Fortrea Holdings (FTRE)	United States	$1.572B	33.35
Tyra Biosciences (TYRA)	United States	$1.571B	0.00
Certara (CERT)	United States	$1.537B	28.38
Alvotech (ALVO)	Luxembourg	$1.519B	21.91
NovoCure (NVCR)	Jersey	$1.518B	0.00
Mind Medicine (MindMed) (MNMD)	United States	$1.480B	0.00
Nurix Therapeutics (NRIX)	United States	$1.462B	0.00
Pharvaris (PHVS)	Netherlands	$1.439B	0.00
Kodiak Sciences (KOD)	United States	$1.417B	0.00
AtaiBeckley Inc (ATAI)	Netherlands	$1.416B	0.00
Oculis Holding AG (OCS)	Switzerland	$1.364B	0.00
Biohaven (BHVN)	United States	$1.362B	0.00
UniQure (QURE)	Netherlands	$1.354B	0.00
Trevi Therapeutics (TRVI)	United States	$1.321B	0.00
Oxford BioMedica (OXBDF)	United Kingdom	$1.309B	0.00
AnaptysBio (ANAB)	United States	$1.293B	0.00
EyePoint (EYPT)	United States	$1.286B	0.00
AbCellera Biologics (ABCL)	Canada	$1.281B	0.00
Sana Biotechnology (SANA)	United States	$1.268B	0.00
Rapport Therapeutics (RAPP)	United States	$1.258B	0.00
Pharming Group (PHAR)	Netherlands	$1.257B	0.00
Pharming Group (PHGUF)	Netherlands	$1.241B	185.00
Day One Biopharmaceuticals (DAWN)	United States	$1.239B	0.00
Immatics (IMTX)	Germany	$1.213B	0.00
Castle Biosciences (CSTL)	United States	$1.196B	163.92
Oric Pharmaceuticals (ORIC)	United States	$1.193B	0.00
Septerna (SEPN)	United States	$1.180B	0.00
Palvella Therapeutics (PVLA)	United States	$1.112B	0.00
Inhibrx Biosciences (INBX)	United States	$1.092B	0.00
MoonLake Immunotherapeutics (MLTX)	Switzerland	$1.073B	0.00
Zenas BioPharma (ZBIO)	United States	$1.052B	0.00
Compass Therapeutics (CMPX)	United States	$1.049B	0.00
Iovance Biotherapeutics (IOVA)	United States	$0.996B	0.00
Ventyx Biosciences (VTYX)	United States	$0.990B	0.00
Phathom Pharmaceuticals (PHAT)	United States	$0.972B	0.00
Nanobiotix S.A - (NBTX)	France	$0.971B	0.00
Vir Biotechnology (VIR)	United States	$0.966B	0.00
Inventiva S.A (IVA)	France	$0.960B	0.00
ArriVent BioPharma (AVBP)	United States	$0.945B	0.00
Bicara Therapeutics (BCAX)	United States	$0.930B	0.00
CureVac (CVAC)	Germany	$0.927B	0.00
BridgeBio Oncology Therapeutics (BBOT)	United States	$0.911B	0.00
Basilea Pharmaceutica AG (BPMUF)	Switzerland	$0.908B	0.00
Urogen Pharma (URGN)	United States	$0.900B	0.00
CytomX Therapeutics (CTMX)	United States	$0.896B	13.23
Pacira BioSciences (PCRX)	United States	$0.871B	9.97
DBV Technologies S.A (DBVT)	France	$0.870B	0.00
Geron (GERN)	United States	$0.855B	0.00
GH Research (GHRS)	Ireland	$0.852B	0.00
YD Bio (YDES)		$0.846B	0.00
Bright Minds Biosciences (DRUG)	United States	$0.837B	0.00
Annexon (ANNX)	United States	$0.819B	0.00
Arvinas (ARVN)	United States	$0.809B	0.00
Gyre Therapeutics (GYRE)	United States	$0.800B	103.75
Janux Therapeutics (JANX)	United States	$0.798B	0.00
Arbutus Biopharma (ABUS)	United States	$0.796B	0.00
MiMedx (MDXG)	United States	$0.789B	14.03
Jade Biosciences (JBIO)	United States	$0.786B	0.00
MapLight Therapeutics (MPLT)	United States	$0.769B	0.00
REGENXBIO (RGNX)	United States	$0.760B	0.00
Kura Oncology (KURA)	United States	$0.759B	0.00
Prime Medicine (PRME)	United States	$0.724B	0.00
BioAge Labs (BIOA)	United States	$0.721B	0.00
Astria Therapeutics (ATXS)	United States	$0.714B	0.00
Cytek Biosciences (CTKB)	United States	$0.706B	0.00
Cullinan Therapeutics (CGEM)	United States	$0.685B	0.00
SELLAS Life Sciences (SLS)	United States	$0.652B	0.00
Sinovac Biotech (SVA)	China	$0.645B	0.00
Gossamer Bio (GOSS)	United States	$0.634B	0.00
EnGene Holdings (ENGN)	Canada	$0.626B	0.00
MeiraGTx Holdings (MGTX)	United States	$0.614B	0.00
LENZ Therapeutics (LENZ)	United States	$0.610B	0.00
Emergent Biosolutions (EBS)	United States	$0.604B	5.81
Evommune (EVMN)	United States	$0.594B	0.00
Ginkgo Bioworks Holdings (DNA)	United States	$0.593B	0.00
Keros Therapeutics (KROS)	United States	$0.579B	12.35
CorMedix Inc (CRMD)	United States	$0.578B	5.35
Replimune (REPL)	United States	$0.570B	0.00
Lexicon Pharmaceuticals (LXRX)	United States	$0.567B	0.00
Fulcrum Therapeutics (FULC)	United States	$0.564B	0.00
LB Pharmaceuticals Inc (LBRX)	United States	$0.550B	0.00
Alto Neuroscience (ANRO)	United States	$0.546B	0.00
Myriad Genetics (MYGN)	United States	$0.544B	0.00
Design Therapeutics (DSGN)	United States	$0.544B	0.00
Prothena (PRTA)	Ireland	$0.521B	0.00
Invivyd (IVVD)	United States	$0.515B	0.00
Niagen Bioscience (NAGE)	United States	$0.495B	38.75
Solid Biosciences (SLDB)	United States	$0.480B	0.00
Bicycle Therapeutics (BCYC)	United Kingdom	$0.479B	0.00
Anavex Life Sciences (AVXL)	United States	$0.474B	0.00
Monopar Therapeutics (MNPR)	United States	$0.470B	0.00
Vanda Pharmaceuticals (VNDA)	United States	$0.469B	0.00
Ocugen (OCGN)	United States	$0.465B	0.00
Northwest Biotherapeutics (NWBO)	United States	$0.458B	0.00
Absci (ABSI)	United States	$0.454B	0.00
Kamada (KMDA)	Israel	$0.448B	21.64
ADC Therapeutics SA (ADCT)	Switzerland	$0.442B	0.00
NovaBridge Biosciences (NBP)	United States	$0.437B	0.00
Entrada Therapeutics (TRDA)	United States	$0.432B	0.00
Verastem (VSTM)	United States	$0.425B	0.00
PureTech Health (PRTC)	United States	$0.418B	0.00
Prima BioMed (IMMP)	Australia	$0.417B	0.00
Kyverna Therapeutics (KYTX)	United States	$0.415B	0.00
DiaMedica Therapeutics (DMAC)	United States	$0.415B	0.00
Zura Bio (ZURA)	United States	$0.411B	0.00
Benitec Biopharma (BNTC)	United States	$0.410B	0.00
Eton Pharmaceuticals (ETON)	United States	$0.407B	0.00
Rocket Pharmaceuticals (RCKT)	United States	$0.399B	0.00
Forte Biosciences (FBRX)	United States	$0.395B	0.00
Autolus Therapeutics (AUTL)	United Kingdom	$0.391B	0.00
PepGen (PEPG)	United States	$0.372B	0.00
BGM Group (BGM)	China	$0.368B	0.00
Enanta Pharmaceuticals (ENTA)	United States	$0.363B	0.00
Allogene Therapeutics (ALLO)	United States	$0.360B	0.00
Contineum Therapeutics (CTNM)	United States	$0.356B	0.00
Tectonic Therapeutic (TECX)	United States	$0.353B	0.00
Aura Biosciences (AURA)	United States	$0.348B	0.00
Puma Biotechnology (PBYI)	United States	$0.347B	9.31
Candel Therapeutics (CADL)	United States	$0.346B	0.00
Aardvark Therapeutics (AARD)	United States	$0.344B	0.00
Foghorn Therapeutics (FHTX)	United States	$0.344B	0.00
AC Immune (ACIU)	Switzerland	$0.341B	0.00
XOMA Royalty (XOMA)	United States	$0.338B	0.00
X4 Pharmaceuticals (XFOR)	United States	$0.328B	0.00
Neumora Therapeutics (NMRA)	United States	$0.326B	0.00
Eupraxia Pharmaceuticals (EPRX)	Canada	$0.325B	0.00
Amarin (AMRN)	Ireland	$0.318B	0.00
Lifecore Biomedical (LFCR)	United States	$0.316B	0.00
Immuneering (IMRX)	United States	$0.313B	0.00
Greenwich LifeSciences (GLSI)	United States	$0.309B	0.00
GENFIT S.A (GNFTY)	France	$0.299B	0.00
Climb Bio (CLYM)	United States	$0.293B	0.00
Abeona Therapeutics (ABEO)	United States	$0.288B	4.70
Neurogene (NGNE)	United States	$0.284B	0.00
Shattuck Labs (STTK)	United States	$0.281B	0.00
Rezolute (RZLT)	United States	$0.280B	0.00
Prenetics Global (PRE)	Hong Kong, SAR China	$0.275B	0.00
Nautilus Biotechnology (NAUT)	United States	$0.275B	0.00
Atea Pharmaceuticals (AVIR)	United States	$0.275B	0.00
Adherex Technologies (FENC)	United States	$0.263B	0.00
Palisade Bio (PALI)	United States	$0.261B	0.00
Immix Biopharma (IMMX)	United States	$0.259B	0.00
Jyong Biotech (MENS)	Taiwan	$0.243B	0.00
Adocia (ADOCY)	France	$0.231B	0.00
Orchestra BioMed Holdings (OBIO)	United States	$0.231B	0.00
Cabaletta Bio (CABA)	United States	$0.225B	0.00
Nuvectis Pharma (NVCT)	United States	$0.220B	0.00
Zentalis Pharmaceuticals (ZNTL)	United States	$0.213B	0.00
CAMP4 Therapeutics (CAMP)	United States	$0.211B	0.00
Voyager Therapeutics (VYGR)	United States	$0.210B	0.00
Alector (ALEC)	United States	$0.210B	0.00
Editas Medicine (EDIT)	United States	$0.207B	0.00
Arcturus Therapeutics Holdings (ARCT)	United States	$0.207B	0.00
Sagimet Biosciences (SGMT)	United States	$0.207B	0.00
C4 Therapeutics (CCCC)	United States	$0.205B	0.00
Tiziana Life Sciences (TLSA)	United Kingdom	$0.203B	0.00
Cartesian Therapeutics (RNAC)	United States	$0.199B	0.00
Coherus Oncology (CHRS)	United States	$0.198B	0.00
Cardiff Oncology (CRDF)	United States	$0.195B	0.00
SAB Biotherapeutics (SABS)	United States	$0.192B	0.00
Crescent Biopharma (CBIO)	United States	$0.191B	0.00
Compugen (CGEN)	Israel	$0.188B	0.00
Vor Biopharma (VOR)		$0.188B	0.00
Humacyte (HUMA)	United States	$0.184B	0.00
Kalaris Therapeutics (KLRS)	United States	$0.183B	0.00
Quince Therapeutics (QNCX)	United States	$0.181B	0.00
Alpha Teknova (TKNO)	United States	$0.176B	0.00
ProQR Therapeutics (PRQR)	Netherlands	$0.173B	0.00
Milestone Pharmaceuticals (MIST)	Canada	$0.171B	0.00
Alps Group (ALPS)	United States	$0.166B	3.03
Rani Therapeutics Holdings (RANI)	United States	$0.164B	0.00
Molecular Partners AG (MOLN)	Switzerland	$0.163B	0.00
Innate Pharma S.A (IPHA)	France	$0.163B	0.00
Opus Genetics (IRD)	United States	$0.163B	0.00
Nkarta (NKTX)	United States	$0.156B	0.00
Codexis (CDXS)	United States	$0.154B	0.00
Black Diamond Therapeutics (BDTX)	United States	$0.146B	7.14
Mersana Therapeutics (MRSN)	United States	$0.145B	0.00
Connect Biopharma Holdings (CNTB)	United States	$0.140B	0.00
Caribou Biosciences (CRBU)	United States	$0.139B	0.00
Elicio Therapeutics (ELTX)	United States	$0.138B	0.00
Anika Therapeutics (ANIK)	United States	$0.137B	0.00
Turn Therapeutics (TTRX)	United States	$0.137B	0.00
Actuate Therapeutics (ACTU)	United States	$0.136B	0.00
Seres Therapeutics (MCRB)	United States	$0.136B	0.00
Fate Therapeutics (FATE)	United States	$0.136B	0.00
Sutro Biopharma (STRO)	United States	$0.135B	0.00
Spero Therapeutics (SPRO)	United States	$0.133B	0.00
Eledon Pharmaceuticals (ELDN)	United States	$0.132B	0.00
MaxCyte (MXCT)	United States	$0.131B	0.00
Whitehawk Therapeutics (WHWK)	United States	$0.131B	0.00
VTv Therapeutics (VTVT)	United States	$0.130B	0.00
Sangamo Therapeutics (SGMO)	United States	$0.128B	0.00
Alpha Cognition (ACOG)	Canada	$0.127B	0.00
Cognition Therapeutics (CGTX)	United States	$0.125B	0.00
Oncolytics Biotech (ONCY)	Canada	$0.124B	0.00
Tenaya Therapeutics (TNYA)	United States	$0.119B	0.00
Ovid Therapeutics (OVID)	United States	$0.117B	0.00
Artiva Biotherapeutics (ARTV)	United States	$0.117B	0.00
Agenus (AGEN)	United States	$0.116B	0.00
Repare Therapeutics (RPTX)	Canada	$0.112B	0.00
Acumen Pharmaceuticals (ABOS)	United States	$0.110B	0.00
Genelux (GNLX)	United States	$0.108B	0.00
Fortress Biotech (FBIO)	United States	$0.107B	0.00
ANIXA BIOSCIENCES INC (ANIX)	United States	$0.106B	0.00
Tharimmune (THAR)	United States	$0.105B	0.00
Seer (SEER)	United States	$0.105B	0.00
Inovio Pharmaceuticals (INO)	United States	$0.101B	0.00
Biomea Fusion (BMEA)	United States	$0.100B	0.00
Citius Oncology (CTOR)	United States	$0.098B	0.00
EXoZymes (EXOZ)	United States	$0.097B	0.00
Tenax Therapeutics (TENX)	United States	$0.097B	0.00
Starpharma Holdings (SPHRY)	Australia	$0.097B	0.00
Chrome Holding (MEHCQ)	United States	$0.096B	0.00
Adverum Biotechnologies (ADVM)	United States	$0.096B	0.00
Coya Therapeutics (COYA)	United States	$0.095B	0.00
Scilex Holding (SCLX)	United States	$0.090B	0.00
BioHarvest Sciences (BHST)	Canada	$0.087B	0.00
Spruce Biosciences (SPRB)	United States	$0.084B	0.00
Mereo BioPharma Group - (MREO)	United Kingdom	$0.084B	0.00
MediciNova (MNOV)	United States	$0.083B	0.00
CalciMedica (CALC)	United States	$0.080B	0.00
ALX Oncology Holdings (ALXO)	United States	$0.080B	0.00
Adagene (ADAG)	China	$0.080B	0.00
ImageneBio (IMA)	United States	$0.079B	0.00
Immunic (IMUX)	United States	$0.079B	0.00
BioStem Technologies (BSEM)		$0.079B	5.51
OKYO Pharma (OKYO)		$0.078B	0.00
XBiotech (XBIT)	United States	$0.078B	0.00
Pliant Therapeutics (PLRX)	United States	$0.077B	0.00
Adicet Bio (ACET)	United States	$0.077B	0.00
Annovis Bio (ANVS)	United States	$0.076B	0.00
Entera Bio (ENTX)	Israel	$0.072B	0.00
Coeptis Therapeutics Holdings (COEP)	United States	$0.071B	0.00
ATyr Pharma (ATYR)	United States	$0.070B	0.00
Adlai Nortye (ANL)	Cayman Islands	$0.068B	0.00
Equillium (EQ)	United States	$0.068B	0.00
BeyondSpring (BYSI)	United States	$0.067B	0.00
InflaRx (IFRX)	Germany	$0.067B	0.00
Tevogen Bio Holdings (TVGN)	United States	$0.066B	0.00
TScan Therapeutics (TCRX)	United States	$0.065B	0.00
CervoMed (CRVO)	United States	$0.061B	0.00
MIRA Pharmaceuticals (MIRA)	United States	$0.058B	0.00
Radiopharm Theranostics - (RADX)	Australia	$0.058B	0.00
MiNK Therapeutics (INKT)	United States	$0.058B	0.00
Grace Therapeutics (GRCE)	United States	$0.057B	0.00
Clene (CLNN)	United States	$0.056B	0.00
Precision BioSciences (DTIL)	United States	$0.053B	0.00
Q32 Bio (QTTB)	United States	$0.051B	0.00
Zhengye Biotechnology Holding (ZYBT)	China	$0.051B	0.00
IBio (IBIO)	United States	$0.050B	0.00
ABVC BioPharma (ABVC)	United States	$0.050B	0.00
Aligos Therapeutics (ALGS)	United States	$0.049B	0.00
Instil Bio (TIL)	United States	$0.048B	0.00
PDS Biotechnology (PDSB)	United States	$0.046B	0.00
NextCure (NXTC)	United States	$0.046B	0.00
Kezar Life Sciences (KZR)	United States	$0.045B	0.00
Galecto (GLTO)	Denmark	$0.045B	0.00
Anebulo Pharmaceuticals (ANEB)	United States	$0.045B	0.00
Tvardi Therapeutics (TVRD)	United States	$0.044B	0.00
INmune Bio (INMB)	United States	$0.044B	0.00
Jasper Therapeutics (JSPR)	United States	$0.043B	0.00
Cingulate (CING)	United States	$0.041B	0.00
BioXcel Therapeutics (BTAI)	United States	$0.040B	0.00
Exicure (XCUR)	United States	$0.040B	0.00
TELA Bio (TELA)	United States	$0.039B	0.00
Elutia (ELUT)	United States	$0.039B	0.00
Passage Bio (PASG)	United States	$0.039B	0.00
OnKure Therapeutics (OKUR)	United States	$0.039B	0.00
Lantern Pharma (LTRN)	United States	$0.038B	0.00
Femasys (FEMY)	United States	$0.037B	0.00
Generation Bio (GBIO)	United States	$0.037B	0.00
RenovoRx (RNXT)	United States	$0.037B	0.00
Celularity (CELU)	United States	$0.036B	0.00
Lisata Therapeutics (LSTA)	United States	$0.036B	0.00
Kyntra Bio Inc (KYNB)	United States	$0.035B	0.00
TuHURA Biosciences (HURA)	United States	$0.035B	0.00
Estrella Immunopharma (ESLA)	United States	$0.034B	0.00
Medicus Pharma (MDCX)	United States	$0.033B	0.00
Atara Biotherapeutics (ATRA)	United States	$0.033B	2.11
Oncobiologics (OTLK)	United States	$0.032B	0.00
AN2 Therapeutics (ANTX)	United States	$0.032B	0.00
Dyadic (DYAI)	United States	$0.032B	0.00
Rein Therapeutics (RNTX)	United States	$0.032B	0.00
Skye Bioscience (SKYE)	United States	$0.031B	0.00
Xilio Therapeutics (XLO)	United States	$0.031B	0.00
Pluri (PLUR)	Israel	$0.030B	0.00
Cue Biopharma (CUE)	United States	$0.030B	0.00
Werewolf Therapeutics (HOWL)	United States	$0.029B	0.00
Barinthus Biotherapeutics (BRNS)	United States	$0.029B	0.00
Rallybio (RLYB)	United States	$0.029B	0.00
Alterity Therapeutics - (ATHE)	Australia	$0.029B	0.00
Senti Biosciences (SNTI)	United States	$0.028B	0.00
Boundless Bio (BOLD)	United States	$0.028B	0.00
Dare Bioscience (DARE)	United States	$0.028B	0.00
Athira Pharma (ATHA)	United States	$0.027B	0.00
Aytu BioPharma (AYTU)	United States	$0.027B	0.00
Genenta Science S.p.A (GNTA)	Italy	$0.025B	0.00
VistaGen Therapeutics (VTGN)	United States	$0.025B	0.00
LeonaBio (LONA)	United States	$0.025B	0.00
Quantum Biopharma (QNTM)	Canada	$0.025B	0.00
Intensity Therapeutics (INTS)	United States	$0.024B	0.00
Lixte Biotechnology Holdings (LIXT)	United States	$0.024B	0.00
Hyperion DeFi (HYPD)	United States	$0.023B	0.00
FibroBiologics (FBLG)	United States	$0.022B	0.00
Neuphoria Therapeutics (NEUP)	United States	$0.022B	0.00
Apollomics (APLM)	United States	$0.021B	0.00
Black Titan (BTTC)	United States	$0.021B	0.00
Pasithea Therapeutics (KTTA)	United States	$0.021B	0.00
Lexaria Bioscience (LEXX)	Canada	$0.020B	0.00
Allarity Therapeutics (ALLR)	United States	$0.019B	0.00
CollPlant Biotechnologies (CLGN)	Israel	$0.018B	0.00
Promis Neurosciences (PMN)	Canada	$0.018B	0.00
BioAtla (BCAB)	United States	$0.018B	0.00
Polyrizon (PLRZ)	Israel	$0.017B	0.00
Cadrenal Therapeutics (CVKD)	United States	$0.017B	0.00
Hoth Therapeutics (HOTH)	United States	$0.016B	0.00
Bionano Genomics (BNGO)	United States	$0.016B	0.00
Applied Therapeutics (APLT)	United States	$0.016B	0.00
IO Biotech (IOBT)	Denmark	$0.015B	0.00
Beyond Air (XAIR)	United States	$0.015B	0.00
Cocrystal Pharma (COCP)	United States	$0.014B	0.00
Soligenix (SNGX)	United States	$0.014B	0.00
BioCardia (BCDA)	United States	$0.014B	0.00
Bolt Biotherapeutics (BOLT)	United States	$0.012B	0.00
Edesa Biotech (EDSA)	Canada	$0.012B	0.00
Sensei Biotherapeutics (SNSE)	United States	$0.012B	0.00
Novogen (KZIA)	Australia	$0.012B	0.00
Biofrontera (BFRI)	United States	$0.012B	0.00
Curis (CRIS)	United States	$0.012B	0.00
IN8bio (INAB)	United States	$0.011B	0.00
Longeveron (LGVN)	United States	$0.011B	0.00
NewcelX (NCEL)	Switzerland	$0.011B	0.00
Imunon (IMNN)	United States	$0.011B	0.00
Mainz Biomed (MYNZ)	Germany	$0.011B	0.00
Chemomab Therapeutics (CMMB)	Israel	$0.011B	0.00
Biorestorative Therapies (BRTX)	United States	$0.010B	0.00
Gelteq (GELS)	Australia	$0.010B	0.00
Cuprina Holdings (Cayman) (CUPR)	Singapore	$0.010B	0.00
Moleculin Biotech (MBRX)	United States	$0.010B	0.00
Akari Therapeutics (AKTX)	United Kingdom	$0.009B	0.00
Alzamend Neuro (ALZN)	United States	$0.009B	0.00
Abpro Holdings (ABP)	United States	$0.009B	0.00
GENPREX (GNPX)	United States	$0.009B	0.00
Aptevo Therapeutics (APVO)	United States	$0.009B	0.00
IMMURON (IMRN)	Australia	$0.008B	0.00
BRIACELL THERAP (BCTX)	Canada	$0.008B	0.00
Purple Biotech (PPBT)	Israel	$0.008B	0.00
GT Biopharma (GTBP)	United States	$0.008B	0.00
Mustang Bio (MBIO)	United States	$0.007B	0.00
Advanced Biomed (ADVB)	United States	$0.007B	0.00
Silexion Therapeutics Corp (SLXN)	Israel	$0.007B	0.00
Dogwood Therapeutics (DWTX)	United States	$0.007B	0.00
MetaVia (MTVA)	United States	$0.006B	0.00
Sunshine Biopharma (SBFM)	United States	$0.006B	0.00
Adial Pharmaceuticals (ADIL)	United States	$0.006B	0.00
Acurx Pharmaceuticals (ACXP)	United States	$0.006B	0.00
KALA BIO (KALA)	United States	$0.006B	0.00
BioAffinity Technologies (BIAF)	United States	$0.006B	0.00
Aprea Therapeutics (APRE)	United States	$0.006B	0.00
Evogene (EVGN)	Israel	$0.005B	0.00
Cyclerion Therapeutics (CYCN)	United States	$0.005B	0.00
VivoSim Labs (VIVS)	United States	$0.005B	0.00
Aspire Biopharma Holdings (ASBP)	United States	$0.005B	0.00
Creative Medical Technology Holdings (CELZ)	United States	$0.005B	0.00
Revelation Biosciences (REVB)	United States	$0.005B	0.00
Silo Pharma (SILO)	United States	$0.005B	0.00
Decoy Therapeutics Inc (DCOY)	United States	$0.005B	0.00
HCW Biologics (HCWB)	United States	$0.004B	0.00
CNS Pharmaceuticals (CNSP)	United States	$0.004B	0.00
AquaBounty Technologies (AQB)	United States	$0.004B	0.00
Avalon GloboCare (ALBT)	United States	$0.004B	0.00
Propanc Biopharma Inc (PPCB)	Australia	$0.004B	0.00
GeoVax Labs (GOVX)	United States	$0.004B	0.00
Artelo Biosciences (ARTL)	United States	$0.003B	0.00
Cardio Diagnostics Holdings (CDIO)	United States	$0.003B	0.00
Ensysce Biosciences (ENSC)	United States	$0.003B	0.00
Arcadia Biosciences (RKDA)	United States	$0.003B	0.00
Bone Biologics (BBLG)	United States	$0.003B	0.00
Scinai Immunotherapeutics (SCNI)	Israel	$0.003B	0.00
Enveric Biosciences (ENVB)	United States	$0.002B	0.00
Onconetix (ONCO)	United States	$0.002B	0.00
Dermata Therapeutics (DRMA)	United States	$0.002B	0.00
Psyence Biomedical (PBM)	Canada	$0.002B	0.00
Biodexa Pharmaceuticals (BDRX)	United Kingdom	$0.001B	0.00
Virax Biolabs Group (VRAX)	United Kingdom	$0.001B	0.00
GRI Bio (GRI)	United States	$0.001B	0.00
NuCana (NCNA)	United Kingdom	$0.000B	0.00
Aceragen (ACGN)	United States	$0.000B	0.00
ARAVIVE, INC (ARAV)	United States	$0.000B	0.00
Cellectis S.A (CLLS)	France	$0.000B	0.00
Clovis Oncology (CLVSQ)	United States	$0.000B	0.00
Celyad SA (CYAD)	Belgium	$0.000B	0.00
CytoMed Therapeutics (GDTC)	Singapore	$0.000B	0.00
Galapagos (GLPG)	Belgium	$0.000B	0.00
Motif Bio Plc (MTFB)	United Kingdom	$0.000B	0.00
NeuroSense Therapeutics (NRSN)	Israel	$0.000B	0.00
PDL BioPharma (PDLI)	United States	$0.000B	0.00
Pulmatrix (PULM)	United States	$0.000B	0.00
TFF Pharmaceuticals (TFFP)	United States	$0.000B	0.00
VectivBio Holding AG (VECT)	Switzerland	$0.000B	0.00